Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome

Neurology

Volumn 59, Issue 6, 2002, Pages 816-824

  Iizuka, T ^a,c   Sakai, F ^a   Suzuki, N ^a   Hata, T ^b   Tsukahara, S ^a   Fukuda, M ^a   Takiyama, Y ^a  

^a KITASATO UNIVERSITY   (Japan)

^b Yokohama Stroke and Brain Center   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; MITOCHONDRIAL DNA;

ADULT; AGED; ARTICLE; BRAIN DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ELECTROENCEPHALOGRAM; EPILEPSY; FEMALE; GENE MUTATION; HUMAN; LACTIC ACIDOSIS; MALE; MELAS SYNDROME; MIGRAINE; MITOCHONDRIAL MYOPATHY; NERVE CELL EXCITABILITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCINTILLATION CAMERA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE;

EID: 0037167550     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.59.6.816     Document Type: Article

References (48)

1. Pavlakis SG, Phillips PC, Dimauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a distinctive clinical syndrome. Ann Neurol 1984;16:481-488.
2. Ohama E, Ohara S, Ikuta F, Tanaka K, Nishizawa M, Miyatake T. Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy. Acta Neuropathol 1987;74:226-233.
3. Horiguchi Y, Fujii T, Imamura S. Purpuric cutaneous manifestations in mitochondrial encephalomyopathy. J Dermatol 1991;18:295-301.
4. Mizukami K, Sasaki M, Suzuki T, et al. Central nervous system changes in mitochondrial encephalomyopathy: light and electron microscopic study. Acta Neuropathol 1992;83:449-452.
5. Sakuta R, Nonaka I. Vascular involvement in mitochondrial myopathy. Ann Neurol 1989;25:594-601.
6. Clark LM, Marks MP, Adalsteinsson E, et al. MELAS: clinical and pathologic correlations with MRI, xenon/CT, and MR spectroscopy. Neurology 1996;46:223-227.
7. Gilchrist JM, Sikirica M, Stopa E, Shanske S. Adult-onset MELAS. Evidence for involvement of neurons as well as cerebral vasculature in stroke like episodes. Stroke 1996;27:1420-1423.
8. Sparaco M, Bonilla E, Dimauro S, Powers JM. Neuropathology of mitochondrial encephalopathies due to mitochondrial DNA defects J Neuropathol Exp Neurol 1993;52:1-10.
9. Molnár MJ, Valikovics A, Molnár S, et al. Cerebral blood flow and glucose metabolism in mitochondrial disorders. Neurology 2000;55:544-548.
10. Leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990;348:651-653.
11. Goto Y, Nonaka I, Horai S. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim Biophys Acta 1991;1097:238-240.
12. Morten KJ, Cooper JM, Brown GK, Lake BD, Pike D, Poulton J. A new point mutation associated with mitochondrial encephalomyopathy. Hum Mol Genet 1993;2:2081-2087.
13. Zeviani M, Muntoni F, Savarese N, et al. A MERRF/MELAS overlap syndrome associated with a new point mutation in the mitochondrial DNA tRNA(Lys) gene. Eur J Hum Biochem Biophys Res Commun 1994;202:1624-1630.
14. L-eu(UUR) gene in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS). Biochem Biophys Res Commun 1994;202:1624-1630.
15. L-eu(UUR) mutation at 3256 associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like symptoms. Biochem Mol Biol Intern 1994;33:1055-1061.
16. Nakamura M, Nakano S, Goto Y, et al. A novel point mutation in the mitochondrial tRNA(Ser(UCN)) gene detected in a family with MERRF/MELAS overlap syndrome. Biochem Biophys Res Commun 1995;214:86-93.
17. Manfredi G, Manfredi G, Schon EA, et al. A new mutation associated with MELAS is located in a mitochondrial DNA polypeptide-coding gene. Neuromuscul Disord 1995;5:391-398.
18. Taylor RW, Chinnery PF, Haldane F, et al. MELAS associated with a mutation in the valine transfer RNA gene of mitochondrial DNA. Ann Neurol 1996;40:459-462.
19. Nishino I, Komatsu M, Kodama S, Horai S, Nonaka I, Goto Y. The 3260 mutation in mitochondrial DNA can cause mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes (MELAS). Muscle Nerve 1996;19:1603-1604.
20. Campos Y, Martin MA, Rubio JC, et al. Bilateral striatal necrosis and MELAS associated with a new T3308C mutation in the mitochondrial ND1 gene. Biophys Res Commun 1997; 238:323-235.
21. (leu)(UUR) gene (A3243T). Biochem Biophys Res Commun 1997;233:637-639.
22. Hanna MG, Nelson IP, Morgan-Hughes JA, Wood NW. MELAS: a new disease associated mitochondrial DNA mutation and evidence for further genetic heterogeneity. J Neurol Neurosurg Psychiatry 1998;65:512-517.
23. de Coo IF, Sistermans EA, de Wijs IJ, et al. A mitochondrial tRNA(Val) gene mutation (G1642A) in a patient with mitochondrial myopathy, lactic acidosis, and stroke-like episodes. Neurology 1998;50:293-295.
24. Beal FM, Howell N, Bodis-Wollner I, eds. Mitochondria and free radicals in neurodegenerative diseases. New York: Wiley-Liss, 1997.
25. Hasegawa H, Matsuoka T, Goto Y, Nonaka I. Strongly succinate dehydrogenase-reactive blood vessels in muscles from patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Ann Neurol 1991;29:601-605.
26. Boyko OB, Burger PC, Shelburne JD, Ingram P. Non-heme mechanisms for T1 shortening: pathologic, CT, and MR elucidation. AJNR Am J Neuroradiol 1992;13:1439-1445.
27. Castillo M, Scatliff JH, Kwock L, et al. Postmortem MR imaging of lobar cerebral infarction with pathologic and in vivo correlation. Radiographics 1996;16:241-250.
28. Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol 1984;16:157-168.
29. Welch KMA, D'Andrea, Tepley N, Barkley G, Ramadan NM. The concept of migraine as a state of central neuronal hyperexcitabiliy. Neurol Clin 1990;8:817-828.
30. Aurora SK, Ahmad BK, Welch KMA, Bhardhjwaj P, Ramadan NM. Transcranial magnetic stimulation confirms hyperexcitability of occipital cortex in migraine. Neurology 1998;50: 1111-1114.
31. Iigaya M, Iizuka T, Yoshimoto K, Sakai F. Clinical significance of PLEDs in acute stage of cardioembolic stroke (in Japanese). Clinical Encephalography 1999;41:23-30.
32. Takahashi S, Tohgi H, Yonezawa H, Obara S, Nagane Y. Cerebral blood flow and oxygen metabolism before and after a stroke-like episode in patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). J Neurol Sci 1998;158:58-64.
33. Gropen TI, Prohovnik I, Tatemichi TK, Hirano M. Cerebral hyperemia in MELAS. Stroke 1994;25:1873-1876.
34. Kamada K, Takeuchi F, Houkin K, et al. Reversible brain dysfunction in MELAS: MEG and (1)H MRS analysis. J Neurol Neurosurg Psychiatry 2001;70:675-678.
35. Nariai T, Ohno K, Akimoto H, et al. Cerebral blood flow, vascular response and metabolism in patients with MELAS syndrome-xenon CT and PET study. Keio J Med 2000;49: A68-70.
36. Watanabe Y, Hashikawa K, Moriwaki H, et al. SPECT findings in mitochondrial encephalomyopathy. J Nucl Med 1998; 39:961-964.
37. Leu[3243]) in tissues of symptomatic relatives with MELAS: the role of mitotic segregation. Neurology 1993;43:1586-1590.
38. Love S, Nicoll JA, Kinrade E. Sequencing and quantitative assessment of mutant and wild-type mitochondrial DNA in paraffin sections from cases of MELAS. J Pathol 1993;170:9-14.
39. LEU mtDNA mutation in MELAS brain. Neurology 1992; 42(suppl 3):282. Abstract.
40. Yoneda M, Maeda M, Kimura H. Fujii A, Katayama K, Kuriyama M. Vasogenic edema on MELAS: a serial study with diffusion-weighted MR imaging. Neurology 1999;53:2182-2184.
41. Oppenheim C, Galanaud D, Samson Y, et al. Can diffusion weighted magnetic resonance imaging help differentiate stroke from stroke-like events in MELAS? J Neurol Neurosurg Psychiatry 2000;69:248-250.
42. Ohshita T, Oka M, Imon Y, et al. Serial diffusion-weighted imaging in MELAS. Neuroradiology 2000;42:651-656.
43. Oldendolf WH, Cornford ME, Brown WJ. The large apparent work capability of the blood-brain barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat. Ann Neurol 1977;1:409-417.
44. Keep RF, Xiang J, Bets AL. Potassium transport at the bloodbrain and blood-CF barriers. In: Drewes LR, Bets AL, eds. Frontiers in cerebral vascular biology: transport and its regulation. New York: Plenum Press, 1993:43-54.
45. Zuckermann EC, Glaser GH. Activation of experimental epileptogenic foci. Arch Neurol 1970;23:358-364.
46. Valanne L, Paetau A, Suomalainen A, Ketonen L, Pihko H. Laminar cortical necrosis in MELAS syndrome: MR and neuropathological observations. Neuropediatrics 1996;27:154-160.
47. Fujii T, Okuno T, Ito M, et al. CT, MRI, and autopsy findings in brain of a patient with MELAS. Pediatr Neurol 1990;6:253-256.
48. Hamazaki S, Okada S, Kusaka H, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. Report of an autopsy. Acta Pathol Jpn 1989;39:599-606.